药物与抗凝论坛-抗凝论坛
Pharmacotherapy and Anticoagulation Forum-Anticoagulation Forum
08/01 15:40-18:00
会场4–长沙厅 (Meeting Room 4–Changsha Hall)
-
15:40-18:00
-
15:40-18:00
-
15:40-16:00女性房颤患者的卒中风险：真实差异还是风险修饰因素Stroke Risk in Women With Atrial Fibrillation: True Risk Factor or Risk Modifier?
-
16:00-16:20左心室血栓的综合策略：不止于抗凝Optimal Management of Left Ventricular Thrombus: Beyond Anticoagulation Alone
-
16:20-16:40脉冲电场消融与射频消融的卒中风险比较：现有证据与临床启示Stroke Risk in Pulsed Field Ablation Versus Radiofrequency Ablation: Current Evidence and Clinical Implications
-
16:40-17:00抗凝治疗新纪元：全球循证医学最新进展Recent Advances in Anticoagulation Therapy: Insights From Contemporary Global Evidence
-
17:00-17:20房颤导管消融术后抗凝管理：新证据与未解之问Anticoagulation After Atrial Fibrillation Ablation: Emerging Evidence and Unresolved Questions
-
17:20-17:40左心耳封堵术后低剂量抗凝获益：从临床事件到认知功能Benefits of Low-Dose Anticoagulation After Left Atrial Appendage Occlusion: From Clinical Events to Cognitive Function
-
17:40-18:00房颤负荷与卒中风险：从关联到因果的再思考Atrial Fibrillation Burden and Stroke Risk: Rethinking Association and Causality